Recognition of contiguous allele-specific peptide elements in the rubella virus E1 envelope protein

Vaccine. 1997 Apr-May;15(6-7):648-52. doi: 10.1016/s0264-410x(96)00194-6.

Abstract

Peptides which bind to human HLA-DRB1 class II molecules in an allele-specific fashion were derived from the immunodominant E1 envelope protein of rubella virus. Two nonoverlapping E1 peptide epitopes were recognized by rubella virus-specific T cells in the context of independent HLA alleles when presented either separately or as a contiguous polypeptide containing both epitopes. Direct binding analysis of potential peptide epitopes to distinct HLA molecules provides a direct approach for selecting antigenic peptides useful for epitope-based vaccine targeted to multiple HLA types.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Alleles*
  • CD4-Positive T-Lymphocytes / immunology*
  • Cell Line, Transformed
  • Epitope Mapping
  • Epitopes, T-Lymphocyte / genetics
  • Epitopes, T-Lymphocyte / immunology
  • HLA-DR Antigens / immunology*
  • HLA-DRB1 Chains
  • Humans
  • Immunodominant Epitopes / genetics
  • Immunodominant Epitopes / immunology
  • Peptides / chemical synthesis
  • Rubella virus / genetics
  • Rubella virus / immunology*
  • Viral Envelope Proteins / genetics
  • Viral Envelope Proteins / immunology*

Substances

  • Epitopes, T-Lymphocyte
  • HLA-DR Antigens
  • HLA-DRB1 Chains
  • Immunodominant Epitopes
  • Peptides
  • Viral Envelope Proteins
  • E1 envelope protein, Rubella virus